Showing results (351-360 of 369) with videos related to
Sort By:
Pageof 37
Cell|September 10, 2014
Organoid cultures derived from patients with advanced prostate cancerDong Gao, Ian Vela, Andrea Sboner, et al.Journal for Immunotherapy of Cancer|August 17, 2022
Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trialKarim Fizazi, Margitta Retz, Daniel P Petrylak, et al.European Urology|September 17, 2022
Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate CancerHong Truong, Kelsey Breen, Subhiksha Nandakumar, et al.The Lancet. Oncology|June 18, 2021
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 studyChung-Han Lee, Amishi Yogesh Shah, Drew Rasco, et al.Nature Medicine|November 27, 2019
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variantsPedram Razavi, Bob T Li, David N Brown, et al.Proceedings of the National Academy of Sciences of the United States of America|May 8, 2019
Genomic correlates of clinical outcome in advanced prostate cancerWassim Abida, Joanna Cyrta, Glenn Heller, et al.JAMA|September 6, 2017
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline TestingDiana Mandelker, Liying Zhang, Yelena Kemel, et al.Lancet (London, England)|December 13, 2016
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trialArjun V Balar, Matthew D Galsky, Jonathan E Rosenberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4Andrew J Armstrong, Michael J Morris, Wassim Abida, et al.Nature Genetics|January 16, 2019
Tumor mutational load predicts survival after immunotherapy across multiple cancer typesRobert M Samstein, Chung-Han Lee, Alexander N Shoushtari, et al.Pageof 37